Advanced search
Publication Cover
Bioengineered Volume 10, 2019 - Issue 1
Submit an article Journal homepage
1,091
Views
8
CrossRef citations to date
0
Altmetric
Research Paper

Expression of long non-coding RNA H19 predicts distant metastasis in minimally invasive follicular thyroid carcinoma

Yan Daia Department of Endocrinology, Linyi Central Hospital, Linyi, Shandong, ChinaORCID Iconhttps://orcid.org/0000-0002-6317-584X
ORCID Icon,
Yuanqing Miaob Department of Medical Network Information Center, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
,
Qingli Zhuc Department of Thyroid surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
,
Mei Gaoc Department of Thyroid surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
&
Fengyun Haod Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4325-6957
ORCID Icon
Pages 383-389 | Received 07 Jul 2019, Accepted 13 Aug 2019, Published online: 06 Sep 2019

References

  • DeLellis RA, Lloyd RV, Heitz PU. World Health Organization classification of tumors: pathology and genetics of tumors of endocrine organs. Lyon: IARC Press; 2004. p. 64–66.
  • Kim HJ, Sung JY, Oh YL, et al. Association of vascular invasion with increased mortality in patients with minimally invasive follicular thyroid carcinoma but not widely invasive follicular thyroid carcinoma. Head Neck. 2014;36:1695–1700.
  • Asari R, Koperek O, Scheuba C, et al. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial. Ann Surg. 2009;249:1023–1031.
  • O’Neill CJ, Vaughan L, Learoyd DL, et al. Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion. Eur J Surg Oncol. 2011;37:181–185.
  • Ban EJ, Andrabi A, Grodski S, et al. Follicular thyroid cancer: minimally invasive tumours can give rise to metastases. ANZ J Surg. 2012;82:136–139.
  • Ito Y, Hirokawa M, Higashiyama T, et al. Prognosis and prognostic factors of follicular carcinoma in Japan: importance of postoperative pathological examination. World J Surg. 2007;31:1417–1424.
  • Ban EJ, Andrabi A, Grodski S, et al. Follicular thyroid cancer: minimally invasive tumours can give rise to metastases. ANZ J Surg. 2012;82:136–139.
  • Gabory A, Jammes H, Dandolo L. The H19 locus: role of an imprinted non-coding RNA in growth and development. Bioessays. 2010;32:473–480.
  • Yoshimura H, Matsuda Y, Yamamoto M, et al. Expression and role of long non-coding RNA H19 in carcinogenesis. Front Biosci (Landmark Ed). 2018;23:614–625.
  • Weidle UH, Birzele F, Kollmorgen G, et al. Long non-coding RNAs and their role in metastasis. Cancer Genomics Proteomics. 2017;14:143–160.
  • Sugino K, Kameyama K, Nagahama M, et al. Does completion thyroidectomy improve the outcome of patients with minimally invasive follicular carcinoma of the thyroid? Ann Surg Oncol. 2014;21:2981–2986.
  • Ban EJ, Andrabi A, Grodski S, et al. Follicular thyroid cancer: minimally invasive tumours can give rise to metastases. ANZ J Surg. 2012;82:136–139.
  • Nikiforov YE, Ohori NP, Hodak SP, et al. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab. 2011;96:3390–3397.
  • Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: the American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1–133.
  • Lan X, Sun W, Dong W, et al. Downregulation of long noncoding RNA H19 contributes to the proliferation and migration of papillary thyroid carcinoma. Gene. 2018;646:98–105.
  • Wang P, Liu G, Xu W, et al. Long noncoding RNA H19 inhibits cell viability, migration, and invasion via downregulation of IRS-1 in thyroid cancer cells. Technol Cancer Res Treat. 2017;16:1102–1112.
  • Liang WQ, Zeng CCF, Sun SM, et al. Long noncoding RNA H19 is a critical oncogenic driver and contributes to epithelial-mesenchymal transition in papillary thyroid carcinoma. Cancer Manag Res. 2019;11:2059–2072.
  • DeGroot LJ, Kaplan EL, Shukla MS, et al. Morbidity and mortality in follicular thyroid cancer. J Clin Endocrinol Metab. 1995;80:2946–2953.
  • Passler C, Scheuba C, Prager G, et al.Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine replete endemic goiter region. Endocr-Relat Cancer 2014;11:131–139.
  • Ito Y, Hirokawa M, Higashiyama T, et al. Prognosis and prognostic factors of follicular carcinoma in Japan: importance of postoperative pathological examination. World J Surg. 2017;31:1417–1424.
  • Sugino K, Kameyama K, Ito K, et al. .Outcomes and prognostic factors of 251 patients with minimally invasive follicular thyroid carcinoma. Thyroid. 2012;22:798–804.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.